Home -> Law Blog Directory -> Personal Injury Law Blogs -> LaBovick Injury Law Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: LaBovick Injury Law BlogBayer's Liquid formulation of Leukine is withdrawn from market
By Brian F. LaBovick, Esq.
Bayer's liquid formulation of Leukine, a growth factor that helps fight infection and disease in appropriate patients by enhancing immune cell function has been withdrawn from the market. The product was withdrawn because of an upward trend in spontaneous reports of adverse reactions, including syncope (fainting), which are temporally correlated with a change in the formulation of liquid Leukine to include edetate disodium (EDTA). The upward trend in adverse reaction reporting rates has not been observed with the use of lyophilized Leukine. The product should not be used by anyone and all unused vials must be returned to the manufacturer.
Bayer letter regarding withdrawal of Leukine
Full post as published by LaBovick Injury Law Blog on January 24, 2008 (boomark / email).
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Trasylol
Bayer Faces Canadian Class Action
Whole Foods Market Recalls Bulk Hazelnuts
Whole Foods Market Recalls Bulk Hazelnuts
Billion Dollar Ice Market
Probed for Price-Fixing
G&J Gourmet Market Cocoa
Recalled for Possible Melamine Contamination

US Patent 7316967 - Flow method for nanocrystal fabrication
US Patent 7326368 - Toxicity reduction of liquid metal using nanoparticles
US Patent 7360851 - Feedback adjustment for nanoimprint lithography density control
An Unhappy Union Insurance Coverage and the Registered Representative







